Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 1
2005 7
2006 13
2007 11
2008 2
2009 9
2010 9
2011 11
2012 13
2013 13
2014 12
2015 8
2016 8
2017 10
2018 7
2019 11
2020 10
2021 11
2022 5
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
Targeted antibody and cytokine cancer immunotherapies through collagen affinity.
Ishihara J, Ishihara A, Sasaki K, Lee SS, Williford JM, Yasui M, Abe H, Potin L, Hosseinchi P, Fukunaga K, Raczy MM, Gray LT, Mansurov A, Katsumata K, Fukayama M, Kron SJ, Swartz MA, Hubbell JA. Ishihara J, et al. Among authors: swartz ma. Sci Transl Med. 2019 Apr 10;11(487):eaau3259. doi: 10.1126/scitranslmed.aau3259. Sci Transl Med. 2019. PMID: 30971453 Free PMC article.
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker.
Mansurov A, Hosseinchi P, Chang K, Lauterbach AL, Gray LT, Alpar AT, Budina E, Slezak AJ, Kang S, Cao S, Solanki A, Gomes S, Williford JM, Swartz MA, Mendoza JL, Ishihara J, Hubbell JA. Mansurov A, et al. Among authors: swartz ma. Nat Biomed Eng. 2022 Jul;6(7):819-829. doi: 10.1038/s41551-022-00888-0. Epub 2022 May 9. Nat Biomed Eng. 2022. PMID: 35534574
Pathogenic Exploitation of Lymphatic Vessels.
Magold AI, Swartz MA. Magold AI, et al. Among authors: swartz ma. Cells. 2022 Mar 12;11(6):979. doi: 10.3390/cells11060979. Cells. 2022. PMID: 35326430 Free PMC article. Review.
Overcoming transport barriers to immunotherapy.
Yu SS, Hubbell JA, Swartz MA. Yu SS, et al. Among authors: swartz ma. Drug Deliv Transl Res. 2021 Dec;11(6):2273-2275. doi: 10.1007/s13346-021-01084-4. Epub 2021 Oct 30. Drug Deliv Transl Res. 2021. PMID: 34718959
Engineering Targeting Materials for Therapeutic Cancer Vaccines.
Briquez PS, Hauert S, de Titta A, Gray LT, Alpar AT, Swartz MA, Hubbell JA. Briquez PS, et al. Among authors: swartz ma. Front Bioeng Biotechnol. 2020 Feb 11;8:19. doi: 10.3389/fbioe.2020.00019. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32117911 Free PMC article. Review.
Modeling tumor microenvironments in vitro.
Wu M, Swartz MA. Wu M, et al. Among authors: swartz ma. J Biomech Eng. 2014 Feb;136(2):021011. doi: 10.1115/1.4026447. J Biomech Eng. 2014. PMID: 24402507 Free PMC article. Review.
Engineering approaches to immunotherapy.
Swartz MA, Hirosue S, Hubbell JA. Swartz MA, et al. Sci Transl Med. 2012 Aug 22;4(148):148rv9. doi: 10.1126/scitranslmed.3003763. Sci Transl Med. 2012. PMID: 22914624 Review.
Engineering opportunities in cancer immunotherapy.
Jeanbart L, Swartz MA. Jeanbart L, et al. Among authors: swartz ma. Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14467-72. doi: 10.1073/pnas.1508516112. Proc Natl Acad Sci U S A. 2015. PMID: 26598681 Free PMC article. Review.
Materials engineering for immunomodulation.
Hubbell JA, Thomas SN, Swartz MA. Hubbell JA, et al. Among authors: swartz ma. Nature. 2009 Nov 26;462(7272):449-60. doi: 10.1038/nature08604. Nature. 2009. PMID: 19940915 Review.
157 results